Precigen, Inc. (PGEN) stock analysis
PGEN · Precigen, Inc.
Latest recorded price: USD 4.30
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -54.6%, free cash flow margin -927.6%, ROIC -136.0%. The model flags 2 risk signals for this company (2 high severity).
Similar companies in Healthcare
- Praxis Precision Medicines, Inc. (PRAX)
- PTC Therapeutics, Inc. - Common Stock (PTCT)
- Palvella Therapeutics, Inc. (PVLA)
- Ultragenyx Pharmaceutical Inc. - Common Stock (RARE)
- Arcus Biosciences, Inc. (RCUS)
- Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)
- Relay Therapeutics, Inc. (RLAY)
- Roivant Sciences Ltd. (ROIV)